LUCID GROUP INC (LCID) Fundamental Analysis & Valuation

NASDAQ:LCID • US5494982029

9.77 USD
-0.07 (-0.71%)
At close: Mar 6, 2026
9.71 USD
-0.06 (-0.61%)
After Hours: 3/6/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This LCID fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LCID. LCID was compared to 35 industry peers in the Automobiles industry. Both the profitability and financial health of LCID have multiple concerns. While showing a medium growth rate, LCID is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. LCID Profitability Analysis

1.1 Basic Checks

  • LCID had negative earnings in the past year.
  • LCID had a negative operating cash flow in the past year.
  • In the past 5 years LCID always reported negative net income.
  • LCID had a negative operating cash flow in each of the past 5 years.
LCID Yearly Net Income VS EBIT VS OCF VS FCFLCID Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -1B -2B -3B -4B

1.2 Ratios

  • With a Return On Assets value of -45.18%, LCID is not doing good in the industry: 62.86% of the companies in the same industry are doing better.
  • LCID has a Return On Equity (-126.27%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -45.18%
ROE -126.27%
ROIC N/A
ROA(3y)-36.71%
ROA(5y)-40.57%
ROE(3y)-81.25%
ROE(5y)-84.8%
ROIC(3y)N/A
ROIC(5y)N/A
LCID Yearly ROA, ROE, ROICLCID Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for LCID so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LCID Yearly Profit, Operating, Gross MarginsLCID Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. LCID Health Analysis

2.1 Basic Checks

  • LCID does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, LCID has more shares outstanding
  • The number of shares outstanding for LCID has been increased compared to 5 years ago.
  • The debt/assets ratio for LCID is higher compared to a year ago.
LCID Yearly Shares OutstandingLCID Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
LCID Yearly Total Debt VS Total AssetsLCID Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • LCID has an Altman-Z score of -3.35. This is a bad value and indicates that LCID is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -3.35, LCID is doing worse than 60.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.72 indicates that LCID is somewhat dependend on debt financing.
  • LCID has a Debt to Equity ratio (0.72) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Altman-Z -3.35
ROIC/WACCN/A
WACC7.55%
LCID Yearly LT Debt VS Equity VS FCFLCID Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B

2.3 Liquidity

  • LCID has a Current Ratio of 1.25. This is a normal value and indicates that LCID is financially healthy and should not expect problems in meeting its short term obligations.
  • LCID has a Current ratio (1.25) which is comparable to the rest of the industry.
  • A Quick Ratio of 0.83 indicates that LCID may have some problems paying its short term obligations.
  • LCID has a Quick ratio (0.83) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.83
LCID Yearly Current Assets VS Current LiabilitesLCID Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. LCID Growth Analysis

3.1 Past

  • LCID shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.11%.
  • The Revenue has grown by 67.58% in the past year. This is a very strong growth!
  • Measured over the past years, LCID shows a very strong growth in Revenue. The Revenue has been growing by 220.94% on average per year.
EPS 1Y (TTM)2.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.55%
Revenue 1Y (TTM)67.58%
Revenue growth 3Y30.57%
Revenue growth 5Y220.94%
Sales Q2Q%122.94%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.52% on average over the next years. This is quite good.
  • Based on estimates for the next years, LCID will show a very strong growth in Revenue. The Revenue will grow by 54.54% on average per year.
EPS Next Y23.98%
EPS Next 2Y21.11%
EPS Next 3Y21.17%
EPS Next 5Y14.52%
Revenue Next Year83.02%
Revenue Next 2Y92.11%
Revenue Next 3Y91.17%
Revenue Next 5Y54.54%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LCID Yearly Revenue VS EstimatesLCID Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B 20B 25B
LCID Yearly EPS VS EstimatesLCID Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10

More info and screens

Find the best growth stocksShow best growing peers

1

4. LCID Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LCID. In the last year negative earnings were reported.
  • Also next year LCID is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LCID Price Earnings VS Forward Price EarningsLCID Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LCID Per share dataLCID EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

  • LCID's earnings are expected to grow with 21.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.11%
EPS Next 3Y21.17%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LCID Dividend Analysis

5.1 Amount

  • No dividends for LCID!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LCID Fundamentals: All Metrics, Ratios and Statistics

LUCID GROUP INC

NASDAQ:LCID (3/6/2026, 8:00:02 PM)

After market: 9.71 -0.06 (-0.61%)

9.77

-0.07 (-0.71%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)02-24
Earnings (Next)05-04
Inst Owners73.28%
Inst Owner Change-18.97%
Ins Owners0.21%
Ins Owner Change-0.22%
Market Cap3.20B
Revenue(TTM)1.35B
Net Income(TTM)-3.79B
Analysts52.94
Price Target21.57 (120.78%)
Short Float %14.18%
Short Ratio5.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25.74%
Min EPS beat(2)-36.05%
Max EPS beat(2)-15.42%
EPS beat(4)1
Avg EPS beat(4)-11.61%
Min EPS beat(4)-36.05%
Max EPS beat(4)14.21%
EPS beat(8)3
Avg EPS beat(8)-5.94%
EPS beat(12)6
Avg EPS beat(12)-4.21%
EPS beat(16)8
Avg EPS beat(16)-2.48%
Revenue beat(2)1
Avg Revenue beat(2)-1.72%
Min Revenue beat(2)-12.96%
Max Revenue beat(2)9.51%
Revenue beat(4)1
Avg Revenue beat(4)-5%
Min Revenue beat(4)-12.96%
Max Revenue beat(4)9.51%
Revenue beat(8)4
Avg Revenue beat(8)-0.42%
Revenue beat(12)4
Avg Revenue beat(12)-7.49%
Revenue beat(16)5
Avg Revenue beat(16)-8.96%
PT rev (1m)-3.92%
PT rev (3m)-11.03%
EPS NQ rev (1m)-1.45%
EPS NQ rev (3m)-34.97%
EPS NY rev (1m)0%
EPS NY rev (3m)-56.08%
Revenue NQ rev (1m)3.47%
Revenue NQ rev (3m)2.35%
Revenue NY rev (1m)1.47%
Revenue NY rev (3m)-3.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.36
P/FCF N/A
P/OCF N/A
P/B 1.07
P/tB 1.07
EV/EBITDA N/A
EPS(TTM)-10.67
EYN/A
EPS(NY)-8.11
Fwd EYN/A
FCF(TTM)-11.6
FCFYN/A
OCF(TTM)-8.95
OCFYN/A
SpS4.13
BVpS9.16
TBVpS9.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -45.18%
ROE -126.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-36.71%
ROA(5y)-40.57%
ROE(3y)-81.25%
ROE(5y)-84.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 192.39%
Cap/Sales 64.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.83
Altman-Z -3.35
F-Score3
WACC7.55%
ROIC/WACCN/A
Cap/Depr(3y)293.87%
Cap/Depr(5y)425.45%
Cap/Sales(3y)108.84%
Cap/Sales(5y)411.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.55%
EPS Next Y23.98%
EPS Next 2Y21.11%
EPS Next 3Y21.17%
EPS Next 5Y14.52%
Revenue 1Y (TTM)67.58%
Revenue growth 3Y30.57%
Revenue growth 5Y220.94%
Sales Q2Q%122.94%
Revenue Next Year83.02%
Revenue Next 2Y92.11%
Revenue Next 3Y91.17%
Revenue Next 5Y54.54%
EBIT growth 1Y-15.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.67%
EBIT Next 3Y26.18%
EBIT Next 5Y17.05%
FCF growth 1Y-30.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45.17%
OCF growth 3YN/A
OCF growth 5YN/A

LUCID GROUP INC / LCID FAQ

What is the ChartMill fundamental rating of LUCID GROUP INC (LCID) stock?

ChartMill assigns a fundamental rating of 2 / 10 to LCID.


What is the valuation status for LCID stock?

ChartMill assigns a valuation rating of 1 / 10 to LUCID GROUP INC (LCID). This can be considered as Overvalued.


Can you provide the profitability details for LUCID GROUP INC?

LUCID GROUP INC (LCID) has a profitability rating of 0 / 10.


What is the financial health of LUCID GROUP INC (LCID) stock?

The financial health rating of LUCID GROUP INC (LCID) is 1 / 10.